{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T07:05:53Z","timestamp":1750316753603},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,11]]},"DOI":"10.7759\/cureus.12624","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T15:45:44Z","timestamp":1610379944000},"source":"Crossref","is-referenced-by-count":6,"title":["A Study of Proton Pump Inhibitors and Other Risk Factors in Warfarin-Associated Gastrointestinal Bleeding"],"prefix":"10.7759","author":[{"given":"Jevon","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umesh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreya","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janos","family":"Molnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Perlmuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Feller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pallavi","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2005.0229.x","article-title":"Bleeding risk index in an anticoagulation clinic: assessment by indication and implications for care","volume":"20","author":"Aspinall SL","year":"2005","unstructured":"Aspinall SL, DeSanzo BE, Trilli LE, Good CB. Bleeding risk index in an anticoagulation clinic: assessment by indication and implications for care. J Gen Intern Med. 2005, 20:1008-13. 10.1111\/j.1525-1497.2005.0229.x","journal-title":"J Gen Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199011293232201","article-title":"The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation","volume":"323","author":"The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators","year":"1990","unstructured":"The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med. 1990, 323:1505-11. 10.1056\/NEJM199011293232201","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(89)91200-2","article-title":"Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study","volume":"333","author":"Petersen P","year":"1989","unstructured":"Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet. 1989, 333:175-9. 10.1016\/s0140-6736(89)91200-2","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000196989.09900.f8","article-title":"Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions","volume":"37","author":"Steiner T","year":"2006","unstructured":"Steiner T, Rosand J, Diringer M. Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. Stroke. 2006, 37:256-62. 10.1161\/01.STR.0000196989.09900.f8","journal-title":"Stroke"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1996.00440100095011","article-title":"Management and prognosis of life-threatening bleeding during warfarin therapy","volume":"156","author":"White RH","year":"1996","unstructured":"White RH, McKittrick T, Takakuwa J, Callahan C, McDonell M, Fihn S. Management and prognosis of life-threatening bleeding during warfarin therapy. Arch Intern Med. 1996, 156:1197-201. 10.1001\/archinte.1996.00440100095011","journal-title":"Arch Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90285-w","article-title":"Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention","volume":"95","author":"Landefeld CS","year":"1993","unstructured":"Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med. 1993, 95:315-28. 10.1016\/0002-9343(93)90285-w","journal-title":"Am J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629090-00002","article-title":"Pharmacokinetic drug interaction profiles of proton pump inhibitors","volume":"29","author":"Blume H","year":"2006","unstructured":"Blume H, Donath F, Warnke A, Schug BS. Pharmacokinetic drug interaction profiles of proton pump inhibitors. Drug Saf. 2006, 29:769-84. 10.2165\/00002018-200629090-00002","journal-title":"Drug Saf"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2174\/138920005774330620","article-title":"Effect of omeprazole on the hydroxylation of warfarin enantiomers in human: in-vitro studies with liver microsomes and cDNA-expressed cytochrome P450 isozymes","volume":"6","author":"Zhou Q","year":"2005","unstructured":"Zhou Q, Zhou S, Chan E. Effect of omeprazole on the hydroxylation of warfarin enantiomers in human: in-vitro studies with liver microsomes and cDNA-expressed cytochrome P450 isozymes. Curr Drug Metab. 2005, 6:399-411. 10.2174\/138920005774330620","journal-title":"Curr Drug Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2003.09.007","article-title":"Effect of omeprazole on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats","volume":"20","author":"Zhou Q","year":"2003","unstructured":"Zhou Q, Chan E. Effect of omeprazole on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats. Eur J Pharm Sci. 2003, 20:439-49. 10.1016\/j.ejps.2003.09.007","journal-title":"Eur J Pharm Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.08.054","article-title":"Association of proton pump inhibitors with reduced risk of warfarin-related serious upper gastrointestinal bleeding","volume":"151","author":"Ray WA","year":"2016","unstructured":"Ray WA, Chung CP, Murray KT, Smalley WE, Daugherty JR, Dupont WD, Stein M. Association of proton pump inhibitors with reduced risk of warfarin-related serious upper gastrointestinal bleeding. Gastroenterology. 2016, 151:1105-1112. 10.1053\/j.gastro.2016.08.054","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2006.03.019","article-title":"Study on warfarin plasma concentration and its correlation with international normalized ratio","volume":"42","author":"Sun S","year":"2006","unstructured":"Sun S, Wang M, Su L, Li J, Li H, Gu D. Study on warfarin plasma concentration and its correlation with international normalized ratio. J Pharm Biomed Anal. 2006, 42:218-22. 10.1016\/j.jpba.2006.03.019","journal-title":"J Pharm Biomed Anal"},{"key":"ref12","article-title":"A 44-year-old woman with hematemesis and cutaneous hemorrhages as a result of superwarfarin poisoning","volume":"106","author":"Dolin EK","year":"2006","unstructured":"Dolin EK, Baker DL, Buck SC. A 44-year-old woman with hematemesis and cutaneous hemorrhages as a result of superwarfarin poisoning. J Am Osteopath Assoc. 2006, 106:280-4.","journal-title":"J Am Osteopath Assoc"},{"key":"ref13","article-title":"Warfarin treatment and bleeding [Article in Norwegian]","volume":"123","author":"Breen AB","year":"2003","unstructured":"Breen AB, Vaskinn TE, Reikvam A, Skovlund E, Lislevand H, Madsen S. Warfarin treatment and bleeding [Article in Norwegian]. Tidsskr Nor Laegeforen. 2003, 123:1835-7.","journal-title":"Tidsskr Nor Laegeforen"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03780.x","article-title":"Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study","volume":"28","author":"Mass\u00f3 Gonz\u00e1lez EL","year":"2008","unstructured":"Mass\u00f3 Gonz\u00e1lez EL, Garc\u00eda Rodr\u00edguez LA. Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study. Aliment Pharmacol Ther. 2008, 28:629-37. 10.1111\/j.1365-2036.2008.03780.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.12.018","article-title":"Peptic ulcerations are related to systemic rather than local effects of low-dose aspirin","volume":"6","author":"van Oijen MG","year":"2008","unstructured":"van Oijen MG, Dieleman JP, Laheij RJ, Sturkenboom MC, Jansen JB, Verheugt FW. Peptic ulcerations are related to systemic rather than local effects of low-dose aspirin. Clin Gastroenterol Hepatol. 2008, 6:309-13. 10.1016\/j.cgh.2007.12.018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref16","article-title":"Angiodysplasia in patients with renal insufficiency","volume":"84","author":"Navab F","year":"1989","unstructured":"Navab F, Masters P, Subramani R, Ortego TJ, Thompson CH. Angiodysplasia in patients with renal insufficiency. Am J Gastroenterol. 1989, 84:1297-301.","journal-title":"Am J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198810000-00003","article-title":"Gastrointestinal angiodysplasia in renal failure","volume":"10","author":"Marcuard SP","year":"1988","unstructured":"Marcuard SP, Weinstock JV. Gastrointestinal angiodysplasia in renal failure. J Clin Gastroenterol. 1988, 10:482-4. 10.1097\/00004836-198810000-00003","journal-title":"J Clin Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.080754","article-title":"Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations","volume":"55","author":"Lanas A","year":"2006","unstructured":"Lanas A, Garcia-Rodriguez LA, Arroyo MT, et al.. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut. 2006, 55:1731-8. 10.1136\/gut.2005.080754","journal-title":"Gut"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.18926\/AMO\/30992","article-title":"Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal anti-inflammatory drugs in","volume":"62","author":"Ishikawa S","year":"2008","unstructured":"Ishikawa S, Inaba T, Mizuno M, et al.. Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal anti-inflammatory drugs in. Japan Acta Med Okayama. 2008, 62:29-36. 10.18926\/AMO\/30992","journal-title":"Japan Acta Med Okayama"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(89)80689-8","article-title":"Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy","volume":"87","author":"Landefeld CS","year":"1989","unstructured":"Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med. 1989, 87:144-52. 10.1016\/s0002-9343(89)80689-8","journal-title":"Am J Med"},{"key":"ref21","article-title":"Improvement of prognosis by home prothrombin estimation in patients with life long anticoagulation therapy","volume":"17","author":"Horstkotte D","year":"1996","unstructured":"Horstkotte D, Piper C, Wiemer M, Schulte HD, Schultheib HP. Improvement of prognosis by home prothrombin estimation in patients with life long anticoagulation therapy. Eur Heart J. 1996, 17:230.","journal-title":"Eur Heart J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.12.007","article-title":"Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population","volume":"132","author":"Garc\u00eda Rodr\u00edguez LA","year":"2007","unstructured":"Garc\u00eda Rodr\u00edguez LA, Barreales Tolosa L. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterology. 2007, 132:498-506. 10.1053\/j.gastro.2006.12.007","journal-title":"Gastroenterology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.1.59","article-title":"Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study","volume":"163","author":"Dalton SO","year":"2003","unstructured":"Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med. 2003, 163:59-64. 10.1001\/archinte.163.1.59","journal-title":"Arch Intern Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.4.2.337","article-title":"Selective serotonin re-uptake inhibitors and the risk of bleeding","volume":"4","author":"Weinrieb RM","year":"2005","unstructured":"Weinrieb RM, Auriacombe M, Lynch KG, Lewis JD. Selective serotonin re-uptake inhibitors and the risk of bleeding. Expert Opin Drug Saf. 2005, 4:337-44. 10.1517\/14740338.4.2.337","journal-title":"Expert Opin Drug Saf"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02859.x","article-title":"Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis","volume":"23","author":"Wessinger S","year":"2006","unstructured":"Wessinger S, Kaplan M, Choi L, et al.. Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis. Aliment Pharmacol Ther. 2006, 23:937-44. 10.1111\/j.1365-2036.2006.02859.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2007.9.1\/dhalperin","article-title":"Influence of antidepressants on hemostasis","volume":"9","author":"Halperin D","year":"2007","unstructured":"Halperin D, Reber G. Influence of antidepressants on hemostasis. Dialogues Clin Neurosci. 2007, 9:47-59. 10.31887\/DCNS.2007.9.1\/dhalperin","journal-title":"Dialogues Clin Neurosci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.11.006","article-title":"Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding?","volume":"119","author":"Yuan Y","year":"2006","unstructured":"Yuan Y, Tsoi K, Hunt RH. Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding?. Am J Med. 2006, 119:719-27. 10.1016\/j.amjmed.2005.11.006","journal-title":"Am J Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3928\/02793695-20070401-06","article-title":"SSRIs & the risk of abnormal bleeding","volume":"45","author":"Reeves RR","year":"2007","unstructured":"Reeves RR, Wise PM, Cox SK. SSRIs & the risk of abnormal bleeding. J Psychosoc Nurs Ment Health Serv. 2007, 45:15-21. 10.3928\/02793695-20070401-06","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff CT","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, et al.. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014, 383:955-962. 10.1016\/S0140-6736(13)62343-0","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.17242","article-title":"Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding","volume":"320","author":"Ray WA","year":"2018","unstructured":"Ray WA, Chung CP, Murray KT, Smalley WE, Daugherty JR, Dupont WD, Stein M. Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding. JAMA. 2018, 320:2221-2230. 10.1001\/jama.2018.17242","journal-title":"JAMA"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/49143-a-study-of-proton-pump-inhibitors-and-other-risk-factors-in-warfarin-associated-gastrointestinal-bleeding","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:41Z","timestamp":1707507161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/49143-a-study-of-proton-pump-inhibitors-and-other-risk-factors-in-warfarin-associated-gastrointestinal-bleeding"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.12624","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,11]]}}}